1. Adamski, S. W., Svensjö, E. S., and Grega, G. J., 1985, Effects of AVP and DDAVP on histamine-induced increases in macromolecular permeability in the hamster cheek pouch, Microcirc. Endothel. Lymphat. 2: 41.
2. Bichet, D. G., Razi, M., Lonergan, M., Arthus, M.-F., Papukna, V., Kortas, G, and Barjon, J.-N., 1988, Hemodynamic and coagulation responses to l-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus, N. Engl. J. Med. 318: 881.
3. Bichet, D. G., Razi, M., Arthus, M.-F., Lonergan, M., Tittley, P., Smiley, R. K., Rock, G., and Hirsch, D. J., 1989, Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism, Kidney Int. 36: 859.
4. Brink, H., Derkx, F., Brommer, E., Stibbe, J., Kolstee, N., and Schalekamp, M., 1987, The fibrinolytic, factor VIII: C, von Willebrand factor and hemodynamic responses to DDAVP in patients with hereditary nephrogenic diabetes insipidus, Thromb. Haemostas. 58: 517.
5. Brommer, E. J. P., Barrett-Bergshoeff, M. M., Allen, R. A., Schicht, L, Bertina, R. M., and Schalekamp, M. A. D. H., 1982, The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients — analysis of responders and non-responders, Thromb. Haemostas. 48: 156.